| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V127970 | A2AAR antagonist 3 | A2AAR antagonist 3 is a selective and potent A2A adenosine receptor (A2A AR) antagonist with an IC50 value of 1.57 nM. | |
|
V119241 | A2AAR antagonist 4 | A2AAR antagonist 4 is an orally effective A2A adenosine receptor antagonist with a Ki value of 0.36 nM and a KB value of 1 nM for human A2AAR. | |
|
V51753 | A2AR-antagonist-1 | 2922920-71-4 | A2AR-antagonist-1 (compound 38) is a potent cervical adenylate A2A receptor (A2AR) clamp antagonist (IC50=29 nM). |
|
V3128 | A2A receptor antagonist 1 | 443103-97-7 | A2A receptor antagonist 1 is a novel and potent antagonist of the adenosine A2A receptor and A1 receptor with Kis of 4 and 264 nM, respectively. |
|
V103545 | A3AR agonist 3 | 3032474-53-3 | A3AR agonist 3 (Compound 15A) is an A3 adenosine receptor (A3AR) agonist with a Ki value of 2.27 nM for hA3 and an EC50 value of 0.20 nM for cAMP. |
|
V92167 | A3AR agonist 4 | 3032475-23-0 | A3AR agonist 4 is a A3 adenosine receptor (A3AR) agonist (Ki 1.24 nM for hA3AR). |
|
V79210 | A3AR modulator 1 | A3AR modulator 1 (MRS8054) is an orally bioactive A3AR (Adenosine Receptor) PAM (positive allosteric modulator). | |
|
V1482 | CGS 21680 HCl | 124431-80-7 | CGS 21680 HCl (CGS21680; CGS-21680), the hydrochloride salt of CGS 21680,is a potent and specific agonist of adenosine A2 receptors with potential antideppressant activity. |
|
V75276 | DPTN dihydrochloride | 325767-87-1 | DPTN is a potent and specific antagonist of human, mouse and rat A3AR with Kis of 1.65, 9.61 and 8.53 nM respectively. |
|
V75262 | MRS-3777 hemioxalate | 1186195-57-2 | MRS-3777 hemioxalate is a selective adenosine A3 receptor blocker (antagonist). |
|
V80840 | MRS7935 | MRS7935 (compound 15) is an A1AR positive allosteric modulator (PAM) with EC50 of about 2 μM. | |
|
V101847 | N 0861 | 141696-90-4 | N-0861 is a novel selective A1 adenosine receptor antagonist that can inhibit the negative conduction effects (prolonged AH interval) and chest pain caused by adenosine, but has no significant effect on the increase in coronary blood flow velocity caused by adenosine. |
|
V2917 | SCH-58261 | 160098-96-4 | SCH-58261 (SCH58261; SCH 58261) is a novel, potent, selective and competitive antagonist of the adenosine A2A receptor with immunomodulatory and neuroprotective effects. |
|
V145482 | SYAF080 | 352692-70-7 | SYAF080 is a human A₂B adenosine receptor (hA₂B AdoR) antagonist with a Ki value of 23.6 nM and a KB value of 25.2 nM. |
|
V84699 | XCC | 96865-83-7 | |
|
V147289 | Zaladenant | 2246426-52-6 | Zaladenant is an adenosine receptor antagonist with antitumor activity. |
|
V1483 | Istradefylline (KW-6002) | 155270-99-8 | Istradefylline (formerly KW6002; KW 6002; KW-6002; Nourianz), a caffeine derivative, is an orally bioavailable and selective adenosine A2A receptor (A2AR) antagonist with anti-PD (Parkinson's disease) effects. |
|
V13165 | Norepinephrine (Levarterenol; L-Noradrenaline) | 51-41-2 | Norepinephrine (Levarterenol; L-Noradrenaline) is a potent and β1-selective adrenergic receptor agonist with EC50 of 5.37 μM. |
|
V16551 | Todralazine hydrochloride | 3778-76-5 | Todralazine HCl (Ecarazine HCl) is an anti-hypertensive (blood pressure lowering) agent, a β2 adrenergic receptor (β2AR) blocker, and has antioxidant and free radical scavenging activities. |
|
V3126 | Acefylline | 652-37-9 | Acefylline (also known as Theophylline-7-acetic acid and Theophyllineacetic acid), is an antagonist of theadenosine receptor and an activator of the peptidylarginine deiminase (PAD). |